메뉴 건너뛰기




Volumn 57, Issue 8, 2013, Pages 617-622

Serum uric acid levels and nonalcoholic fatty liver disease in Uyghur and han ethnic groups in northwestern China;Concentração sérica de ácido úrico e doença hepática gordurosa não alcoólica em grupos étnicos uyghur e han no nordeste da China

Author keywords

Han; Hyperuricemia; Non alcoholic fatty liver disease; Serum uric acid; Uyghur

Indexed keywords

URIC ACID;

EID: 84890729058     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000800006     Document Type: Article
Times cited : (28)

References (17)
  • 1
    • 68049142588 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease pathogenesis: The present and the future
    • Petta S, Muratore C, Craxi A. Nonalcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009;41:615-25.
    • (2009) Dig Liver Dis , vol.41 , pp. 615-625
    • Petta, S.1    Muratore, C.2    Craxi, A.3
  • 2
    • 76649083261 scopus 로고    scopus 로고
    • Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
    • Lee YJ, Lee HR, Lee JH, Shin YH, Shim JY. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med. 2010;48:175-80.
    • (2010) Clin Chem Lab Med , vol.48 , pp. 175-180
    • Lee, Y.J.1    Lee, H.R.2    Lee, J.H.3    Shin, Y.H.4    Shim, J.Y.5
  • 3
    • 77955366821 scopus 로고    scopus 로고
    • High serum uric acid increases the risk for non-alcoholic fatty liver disease: A prospective observational study
    • Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for non-alcoholic fatty liver disease: a prospective observational study. PLoS. 2010;14:e11578.
    • (2010) PLoS , vol.14
    • Xu, C.1    Yu, C.2    Xu, L.3    Miao, M.4    Li, Y.5
  • 4
    • 64549089599 scopus 로고    scopus 로고
    • Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
    • Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatology. 2009;50:1029-34.
    • (2009) J Hepatology , vol.50 , pp. 1029-1034
    • Li, Y.1    Xu, C.2    Yu, C.3    Xu, L.4    Miao, M.5
  • 5
    • 79953734064 scopus 로고    scopus 로고
    • The relationship between normal serum uric acid and nonalcoholic fatty liver disease
    • Hwang IC, Suh JY, Suh AR, Ahn HY. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci. 2011;26:389-91.
    • (2011) J Korean Med Sci , vol.26 , pp. 389-391
    • Hwang, I.C.1    Suh, J.Y.2    Suh, A.R.3    Ahn, H.Y.4
  • 6
    • 77957574094 scopus 로고    scopus 로고
    • Serum uric acid as a predictor for the development of non-alcoholic fatty liver disease in apparently healthy subjects: A 5-year retrospective cohort study
    • Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric acid as a predictor for the development of non-alcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4:378-83.
    • (2010) Gut Liver , vol.4 , pp. 378-383
    • Lee, J.W.1    Cho, Y.K.2    Ryan, M.3    Kim, H.4    Lee, S.W.5    Chang, E.6
  • 8
    • 80052501527 scopus 로고    scopus 로고
    • Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease
    • Petta S, Camma C, Cabibi D, DiMarco V, Craxi A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment PharmacolTher. 2011;34:757-66.
    • (2011) Aliment PharmacolTher , vol.34 , pp. 757-766
    • Petta, S.1    Camma, C.2    Cabibi, D.3    Dimarco, V.4    Craxi, A.5
  • 10
    • 27644510537 scopus 로고    scopus 로고
    • Review article: Role of oxidative stress in the progression of non-alcoholic steatosis
    • Albano E, Mottaran E, Occhino G, Reale E, Vidali M. Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther. 2005;22 Suppl 2:71-3.
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.2 SUPPL. , pp. 71-73
    • Albano, E.1    Mottaran, E.2    Occhino, G.3    Reale, E.4    Vidali, M.5
  • 12
    • 0034888485 scopus 로고    scopus 로고
    • Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
    • Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol. 2001;38:365-71.
    • (2001) J Cardiovasc Pharmacol , vol.38 , pp. 365-371
    • Waring, W.S.1    Webb, D.J.2    Maxwell, S.R.3
  • 14
    • 13144253218 scopus 로고    scopus 로고
    • Uric acid: A new look at an old riskmarker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
    • Hayden MR, Tyagi SC. Uric acid: a new look at an old riskmarker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond). 2004;1:10.
    • (2004) Nutr Metab (Lond) , vol.1 , pp. 10
    • Hayden, M.R.1    Tyagi, S.C.2
  • 15
    • 69249165852 scopus 로고    scopus 로고
    • Allopurinol, an inhibitor of uric acid synthesis - Can it be used for the treatment of metabolic syndrome and related disorders?
    • Suzuki I, Yamauchi T, Onuma M, Nozaki S. Allopurinol, an inhibitor of uric acid synthesis - Can it be used for the treatment of metabolic syndrome and related disorders? Drugs Today (Barc). 2009;45:363-78.
    • (2009) Drugs Today (Barc) , vol.45 , pp. 363-378
    • Suzuki, I.1    Yamauchi, T.2    Onuma, M.3    Nozaki, S.4
  • 17
    • 84890725079 scopus 로고    scopus 로고
    • The relationship between fatty liver and hyperuricemia
    • Hu C-b, Shi J-p. The relationship between fatty liver and hyperuricemia. Chinese Hepatol. 2011;16:202-5.
    • (2011) Chinese Hepatol , vol.16 , pp. 202-205
    • Hu, C.-B.1    Shi, J.-P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.